Zoetis (ZTS) Asset Writedowns and Impairment (2012 - 2026)

Zoetis (ZTS) has 15 years of Asset Writedowns and Impairment data on file, last reported at $13.0 million in Q1 2026.

• Asset Writedowns and Impairment for Q1 2026 came in at $13.0 million, up 550.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.0 million (up 53.57% YoY), and the FY2025 annual result was $47.0 million, down 51.55% from the prior year.
• Asset Writedowns and Impairment improved to $13.0 million in Q1 2026 per ZTS's latest filing, from $8.0 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $46.0 million in Q4 2022 and troughed at $1.0 million in Q1 2023.
• A 5-year average of $15.2 million and a median of $9.0 million in 2022 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment jumped 800.0% in 2022, then slumped 88.89% in 2023.
• A 5-year view of Asset Writedowns and Impairment shows it stood at $46.0 million in 2022, then plunged by 58.7% to $19.0 million in 2023, then soared by 36.84% to $26.0 million in 2024, then slumped by 69.23% to $8.0 million in 2025, then soared by 62.5% to $13.0 million in 2026.
• Business Quant data shows ZTS's Asset Writedowns and Impairment at $13.0 million in Q1 2026, $8.0 million in Q4 2025, and $22.0 million in Q2 2025.